EVERSIGHT: Form 990, tax year 2020
View the entire original 990 at ProPublica ↗
- Organization
- EVERSIGHT (EIN 38-2117115)
- Tax period
- 2020-01-01 to 2020-12-31
- Filed
- 2021-06-24
- IRS object ID
- 202101759349300010
- Schema version
- 2020v4.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule G
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-06-24T07:50:58-05:00 | ReturnTs |
| Tax Period End | 2020-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 382706146 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | YEO & YEO PC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1450 EISENHOWER PLACE | AddressLine1Txt |
| City | ANN ARBOR | CityNm |
| State Abbreviation | MI | StateAbbreviationCd |
| ZIP | 481083283 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2020-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 382117115 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EVERSIGHT | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | EVER | BusinessNameControlTxt |
| Phone | 8002477250 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3985 RESEARCH PARK DR | AddressLine1Txt |
| City | ANN ARBOR | CityNm |
| State Abbreviation | MI | StateAbbreviationCd |
| ZIP | 48108 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | DIANE HOLLINGSWORTH | PersonNm |
| Person Title | PRESIDENT & CEO | PersonTitleTxt |
| Phone | 8002477250 | PhoneNum |
| Signature | 2021-06-21 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | DIANE | PersonFirstNm |
| Person Last | HOLLINGSWORTH | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | BRIAN R DIXON | PreparerPersonNm |
| PTIN | P01321580 | PTIN |
| Phone | 7347691331 | PhoneNum |
| Preparation | 2021-06-21 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2020 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | DIANE HOLLINGSWORTH | PrincipalOfficerNm |
| Gross Receipts | $26,663,962 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.EVERSIGHTVISION.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1986 | FormationYr |
| Legal Domicile State | MI | LegalDomicileStateCd |
| Activity Or Mission | EVERSIGHT IS A 501(C)3 NONPROFIT ORGANIZATION WITH THE MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. THE EVERSIGHT NETWORK IS RESPONSIBLE FOR RECOVERING, EVALUATING AND PROVIDING HUMAN EYE TISSUE FOR TRANSPLANTATION; ADVANCING RESEARCH INTO THE CAUSES AND CURES OF BLINDING EYE CONDITIONS; PROMOTING DONATION AWARENESS THROUGH PUBLIC AND PROFESSIONAL EDUCATION; AND PROVIDING HUMANITARIAN AID TO PEOPLE AROUND THE WORLD IN NEED OF CORNEAL TRANSPLANTATION. FOUNDED IN 1947, EVERSIGHT MAINTAINS ITS COMMITMENT TO EXCELLENCE AS AN ACCREDITED MEMBER OF THE EYE BANK ASSOCIATION OF AMERICA (EBAA) AND BY MEETING THE HIGHEST QUALITY STANDARDS SET BY THE U.S. FOOD AND DRUG ADMINISTRATION. THE NONPROFIT OPERATES 24/7/365 IN CONNECTICUT, ILLINOIS, MICHIGAN, NEW JERSEY, OHIO AND SOUTH KOREA, AND COLLABORATES WITH SURGEONS, RESEARCHERS, ACADEMIC MEDICAL CENTERS AND EYE BANKS ACROSS THE UNITED STATES AND ABROAD. EVERSIGHT WORKS WITH THE | ActivityOrMissionDesc |
| Voting Members Governing Body | 11 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 11 | VotingMembersIndependentCnt |
| Total Employee | 176 | TotalEmployeeCnt |
| Total Volunteers | 124 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $1,197,972 | PYContributionsGrantsAmt |
| CY Contributions Grants | $672,370 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $21,313,494 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $19,849,742 | CYProgramServiceRevenueAmt |
| PY Investment Income | $511,589 | PYInvestmentIncomeAmt |
| CY Investment Income | $453,662 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$144,883 | PYOtherRevenueAmt |
| CY Other Revenue | $21,345 | CYOtherRevenueAmt |
| PY Total Revenue | $22,878,172 | PYTotalRevenueAmt |
| CY Total Revenue | $20,997,119 | CYTotalRevenueAmt |
| CY Grants And Similar Paid | $0 | CYGrantsAndSimilarPaidAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $11,536,515 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $10,918,716 | CYSalariesCompEmpBnftPaidAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $641,265 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $10,136,975 | PYOtherExpensesAmt |
| CY Other Expenses | $9,554,849 | CYOtherExpensesAmt |
| PY Total Expenses | $21,673,490 | PYTotalExpensesAmt |
| CY Total Expenses | $20,473,565 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $1,204,682 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $523,554 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $33,975,355 | TotalAssetsBOYAmt |
| Total Assets EOY | $36,782,737 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $20,882,096 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $22,450,700 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $13,093,259 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $14,332,037 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | EVERSIGHT'S MISSION IS TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. BLINDING EYE DISEASES AFFECT 80 MILLION AMERICANS. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, DRIVE TO WORK OR READ THE NEWSPAPER ON A SUNDAY MORNING. THEIR VISION LOSS RESULTS IN AN ECONOMIC IMPACT OF 51.4 BILLION EVERY YEAR IN THE UNITED STATES ALONE. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL MOTHERS CAN SEE THEIR CHILDREN AND ALL CHILDREN CAN GROW UP TO LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. TO MAKE VISION A REALITY FOR ALL, EVERSIGHT CONTINUOUSLY WORKS TO EXPAND ITS REACH, CONNECT MORE EFFECTIVELY WITH COMMUNITIES IN NEED AND PROVIDE THE GIFT OF SIGHT TO EVERYONE. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $9,561,912 | ExpenseAmt |
| Revenue | $18,207,612 | RevenueAmt |
| Desc | RESORING SIGHT IN 2020, EVERSIGHT PROVIDED THE GIFT OF SIGHT TO MORE THAN 6,500 PEOPLE ACROSS THE UNITED STATES AND AROUND THE WORLD. EVERSIGHT'S WORK BEGAN IN 1947 WITH THE ESTABLISHMENT OF THE FOURTH EYE BANK IN THE UNITED STATES, THEN KNOWN AS THE ILLINOIS EYE-BANK. OVER TIME, NONPROFIT EYE BANKS WERE ESTABLISHED IN EVERY STATE TO MEET THE CRITICAL DEMAND FOR CORNEAL TISSUE TO TREAT PREVENTABLE BLINDNESS. IN 1985, THE ILLINOIS EYE-BANK AND MICHIGAN EYE-BANK FORMED A PARTNERSHIP- ONE THAT WOULD EARN A REPUTATION FOR CLINICAL EXCELLENCE MADE POSSIBLE BY SOME OF THE FINEST MEDICAL DIRECTORS, STAFF AND BOARD MEMBERS IN THE EYE BANKING FIELD. THE SUCCESS OF THE ORGANIZATION ATTRACTED AFFILIATIONS WITH OTHER REGIONAL EYE BANKS FORMING ONE OF THE LARGEST NETWORKS OF EYE BANKS IN THE U.S. IN 2015, THE NETWORK BECAME KNOWN AS EVERSIGHT, ALL WORKING TOGETHER AS A UNIFIED OPERATION TO DELIVER THE HIGHEST QUALITY SERVICES TO SURGEONS AND THEIR PATIENTS AND TO CONTINUE TO GROW OUR IMPACT AROUND THE WORLD. EVERSIGHT FACED CHALLENGES IN 2020 AND SAW THEM THROUGH TO SERVE OUR SURGEONS, THEIR PATIENTS AND DONOR FAMILIES. ON MARCH 18, 2020, U.S. CORNEA TRANSPLANTS WERE IMMEDIATELY HALTED DUE TO THE PANDEMIC. NO ONE KNEW HOW LONG IT WOULD LAST, BUT WITH SACRIFICE, INNOVATION AND STEADFAST DETERMINATION, WE KEPT HOPE IN SIGHT. AS THE VIRUS RAPIDLY SPREAD, NO ONE KNEW WHEN TRANSPLANTS MIGHT RESUME AND THE FINANCIAL IMPACT WAS IMMEDIATE. PROVIDING FOR CORNEA TRANSPLANTATION ACCOUNTS FOR 94 PERCENT OF EVERSIGHT'S OPERATING REVENUE, AND LIKE MANY NONPROFITS, WE CANCELED FUNDRAISERS WE COUNT ON TO SUPPORT OUR WORK. THAT INCLUDED OUR ANNUAL GALA, OUR LARGEST ANNUAL FUNDRAISER TO HELP LOW-INCOME PATIENTS. MEANWHILE, THE PANDEMIC WAS ELIMINATING JOBS AND HEALTH INSURANCE COVERAGE AT HISTORIC RATES ACROSS THE COUNTRY. EVEN WITH NO REVENUE COMING IN, WE DEVELOPED NEW PROTOCOLS, TESTING, TRAINING AND READINESS TO MEET THE DEMAND ONCE TRANSPLANTS COULD RESUME. IN JUNE 2020, WE WENT ABOVE AND BEYOND REGULATORY GUIDANCE AND BEGAN TESTING POTENTIAL SURGICAL TISSUE DONORS FOR SARS-COV-2. THE TEAM'S EXPERTISE AND OUR RIGOROUS STANDARDS HELPED ENSURE PATIENT SAFETY AND THE SAFETY OF DONORS' GIFTS OF TISSUE FOR TRANSPLANTATION, ONCE TRANSPLANTS COULD RESUME. IN THIS NEW PHYSICALLY DISTANCED WORLD, WE QUICKLY DEVELOPED AND BEGAN OFFERING VIRTUAL WEBINARS TO HELP SURGEONS STAY ON TOP OF EVOLVING TECHNOLOGY AND COVID-19 SCIENCE AND SAFETY. EVERSIGHT BECAME THE FIRST EYE BANK TO DEVELOP VIRTUAL WET LAB TRAINING FOR SURGEONS TO PRACTICE THEIR SURGICAL TECHNIQUES. WE PROVIDED THE TECHNOLOGY FOR SURGEONS-WHEREVER THEY ARE IN THE WORLD-TO COME TOGETHER ONLINE AND PRACTICE WITH INDIVIDUALIZED REAL-TIME GUIDANCE FROM LEADING SURGEON INSTRUCTORS. MORE THAN 640 SURGEONS AND OTHER CLINICIANS RECEIVED TRAINING THROUGH EVERSIGHT IN 2020, MORE THAN DOUBLING OUR IMPACT OVER ANY PRIOR YEAR. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,036,072 | ExpenseAmt |
| Revenue | $442,060 | RevenueAmt |
| Desc | FINDING A CURE IN THE PURSUIT TO ELIMINATE BLINDING EYE DISEASES, EVERSIGHT ESTABLISHED THE EVERSIGHT CENTER FOR VISION AND EYE BANKING RESEARCH IN CLEVELAND, OHIO, TO PROVIDE LEADING OPHTHALMOLOGY RESEARCHERS WITH THE RESOURCES THEY NEED TO FIND CURES AND TREATMENTS FOR EYE DISEASES SUCH AS AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY AND GLAUCOMA. EVERSIGHT PROVIDED MORE THAN 2,600 TISSUES FOR RESEARCH AND EDUCATION PURPOSES IN 2020. OUR IN-HOUSE RESEARCH TEAM ALSO PROVIDED EVERSIGHT PARTNERS WITH VALUABLE RESEARCH AND DEVELOPMENT SERVICES, AND PIONEERED NEW EYE BANKING PRACTICES, INCLUDING CRITICAL CLINICAL ADAPTATIONS FOR TISSUE SAFETY DURING THE PANDEMIC. OUR RESEARCH AND CLINICAL LEADERSHIP AND STAFF ARE HIGHLY INVOLVED PRIMARY AND CO-INVESTIGATORS, PERFORMING RESEARCH AND AUTHORING PUBLICATIONS THAT EXPAND THE BOUNDARIES OF VISION SCIENCE, KNOWLEDGE AND POSSIBILITY. EVERSIGHT PRODUCED THE RESEARCH THE WORLD NEEDED IN 2020, INVESTIGATING IF SARS-COV-2 IS PRESENT IN EYE TISSUE. OUR WORK TOOK PLACE IN CLEVELAND, CHICAGO, ANN ARBOR AND IN NEW JERSEY-ALL HEAVILY IMPACTED BY COVID-19-WITH RESEARCH PARTNERS AT CHICAGO CORNEA CONSULTANTS AND RUSH UNIVERSITY, KELLOGG EYE CENTER AND THE UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, AND WAYNE STATE UNIVERSITY. BY OCTOBER 2020, OUR FINDINGS SHOWED A SMALL BUT NOTEWORTHY PREVALENCE OF SARS-COV-2 IN OCULAR TISSUES FROM INDIVIDUALS WHO DIED FROM COVID-19. OUR RESEARCH CONTINUES FOR ALL THOSE IN NEED OF SAFE SIGHT-RESTORING TRANSPLANTS AND FOR ALL THOSE AWAITING A CURE FOR NON- CORNEAL BLINDNESS. EVERSIGHT HAS A LONGSTANDING TRACK RECORD OF RESEARCH AND DEVELOPMENT, TO DATE AWARDING MORE THAN 4 MILLION IN GRANTS THAT STIMULATE PIONEERING CLINICAL AND BASIC SCIENCE RESEARCH AIMING TO DEVELOP NEW WAYS TO RESTORE SIGHT, PREVENT BLINDNESS AND ULTIMATELY HELP PATIENTS LIVE LIFE TO THE FULLEST. SINCE 1980, OUR EYE & VISION RESEARCH GRANT PROGRAM HAS SUPPORTED RESEARCHERS AT LEADING ACADEMIC MEDICAL INSTITUTIONS INCLUDING HARVARD, TUFTS, CLEVELAND CLINIC, CASE WESTERN RESERVE, UNIVERSITY OF MICHIGAN, NORTHWESTERN AND MORE. BY DESIGN, EVERSIGHT'S GRANT PROGRAM PROVIDES CRITICAL, EARLY-STAGE FUNDING THAT IS INTENDED TO DRIVE FOUNDATIONAL RESEARCH AND DISCOVERY. MANY OF THESE PROJECTS HAVE STIMULATED LARGER-SCALE STUDIES AND WON FURTHER FINANCIAL SUPPORT FROM THE NATIONAL INSTITUTES OF HEALTH. IN THE 2020-2021 FUNDING CYCLE, EVERSIGHT AWARDED GRANTS TO ADVANCE STUDIES ON TRANSPLANT GRAFT REJECTION, SARS-COV-2 AND THE EYE, FUCHS DYSTROPHY, DRY EYE AND NOVEL CORNEA THERAPIES, LED BY RESEARCHERS AT HARVARD MEDICAL SCHOOL, UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE AND WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE. EACH YEAR, RECIPIENTS ARE SELECTED BY AN INDEPENDENT REVIEW PANEL OF ACADEMIC RESEARCHERS AND OPHTHALMOLOGISTS. THIS DISTINGUISHED PANEL AWARDS PROPOSALS THAT ALIGN WITH EVERSIGHT'S MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH MEANINGFUL SCIENTIFIC INQUISITION. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $4,854,554 | ExpenseAmt |
| Revenue | $1,200,070 | RevenueAmt |
| Desc | SUSTAINABLE INTERNATIONAL IMPACT EVERSIGHT WORKED WITH SURGEONS IN 27 COUNTRIES IN 2020 TO PROVIDE THE GIFT OF SIGHT THROUGH SURGICAL TISSUE PROVISION. EVERSIGHT IS FOCUSED ON MEETING THE HUMANITARIAN NEED FOR CORNEA TISSUES IN COUNTRIES WHERE SIGHT-RESTORING CORNEAL TRANSPLANT PROCEDURES WOULD OTHERWISE BE COMPLETELY UNAVAILABLE. THE BENEFICIARIES OF OUR SURGICAL TISSUE PROVISION AND COMMUNITY EYE BANK DEVELOPMENT INITIATIVES INCLUDE THE HUNDREDS OF THOUSANDS OF PEOPLE WHO SUFFER FROM EYE INJURIES AND BLINDING EYE DISEASES THAT CAN BE TREATED THROUGH CORNEAL TRANSPLANTATION. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. TO ADDRESS SYSTEMIC UNMET NEED, EVERSIGHT ACTIVELY WORKS WITH MEDICAL PROFESSIONALS, GOVERNMENTS, VISION HEALTH ORGANIZATIONS AND OTHER NGOS IN REGIONS LACKING EYE BANKS AND INFRASTRUCTURE, INCLUDING THE MIDDLE EAST, PAKISTAN AND SOUTH KOREA. WITH PROVEN EYE BANKING AND TECHNICAL TRAINING PRACTICES-AND HAVING PLAYED A PART IN THE ELIMINATION OF THE U.S. CORNEA TRANSPLANT WAITING LIST-EVERSIGHT UNIQUELY QUALIFIED TO WORK WITH COUNTRIES LACKING TRANSPLANT PROGRAMS TO HELP THEM ESTABLISH A NATIONAL NETWORK FOR EYE BANKING AND CORNEA DONATION WITH CULTURALLY APPROPRIATE DONATION MODELS AND STATE-OF-THE-ART CLINICAL CAPABILITIES. EIGHTY-NINE PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. IN 2019, EVERSIGHT WORKED WITH PAKISTAN TO OPEN ITS FIRST STATE-OF-THE-ART EYE BANKS AS PART OF A NEW NATIONAL EYE BANKING NETWORK. THE PANDEMIC SUSPENDED MOST OF OUR PLANNED WORK FOR 2020 TO HELP PAKISTAN DEVELOP ITS EYE BANKING AND COMMUNITY DONATION PROGRAM. DESPITE THE CHALLENGES OF THE PANDEMIC, THE NEW AL SHIFA EYE BANK IN RAWALPINDI WORKED WITH ITS FIRST EVER LOCAL EYE TISSUE DONOR IN JULY 2020. WE COLLABORATED WITH AL SHIFA STAFF ON OPTIMIZING DONOR FAMILY AND RECIPIENT COMMUNICATIONS, AND SUPPORTED THEIR FIRST-EVER PUBLIC OUTREACH CAMPAIGN. THE WORK CONTINUES-AND IT HAS GENERATED A NATIONAL MOVEMENT FOR ORGAN, TISSUE AND EYE DONOR REGISTRATION LED BY LOCAL PROFESSIONALS WHO TIRELESSLY EDUCATE AND ADVOCATE FOR THE GIFT OF SIGHT. BLINDING EYE DISEASES AFFECT HUNDREDS OF MILLIONS WORLDWIDE. GLOBALLY, AN ESTIMATED 285 MILLION PEOPLE ARE VISUALLY IMPAIRED-MANY WITH TREATABLE CONDITIONS, BUT WITHOUT ACCESS TO CARE. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, LET ALONE WORK TO PROVIDE FOR THEIR FAMILIES. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE IN THEIR COMMUNITIES. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. WHILE PROVIDING FOR IMMEDIATE GLOBAL CORNEA TRANSPLANT NEEDS WITH U.S. DONOR TISSUE, EVERSIGHT CONTINUES TO EMPOWER INTERNATIONAL COMMUNITIES TO TAKE MEANINGFUL, SUSTAINABLE STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $15,452,538 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | false | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | false | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | false | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 30 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 176 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Form8899 Filedind | false | Form8899Filedind |
| Form1098 C Filed | false | Form1098CFiledInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 11 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 11 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JULIE COLLINS | PersonNm |
| Phone | 7347802119 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3985 RESEARCH PARK DR | AddressLine1Txt |
| City | ANN ARBOR | CityNm |
| State Abbreviation | MI | StateAbbreviationCd |
| ZIP | 48108 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (22 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| DAVID BOSCH | |||||||||
| PRESIDENT & | 50.00 | Yes (X) | $261,757 | $0 | $71,507 | ||||
| MICHAEL O'KEEFE | |||||||||
| COO | 50.00 | $184,030 | $0 | $51,638 | Yes (X) | ||||
| JULIE COLLINS | |||||||||
| CFO | 40.00 | $187,675 | $0 | $52,564 | Yes (X) | 7.50 | |||
| MICHAEL TITUS | |||||||||
| VP CLINICAL | 50.00 | $150,924 | $0 | $53,576 | Yes (X) | ||||
| TERESA CLARK | |||||||||
| VP PHILANTHR | 50.00 | $100,130 | $0 | $45,395 | Yes (X) | ||||
| DIANE HOLLINGSWORTH | |||||||||
| PRESIDENT & | 50.00 | $172,568 | $0 | $45,467 | Yes (X) | ||||
| JAROLD ANDERSON | |||||||||
| CHAIR | 1.00 | $0 | $0 | $0 | Yes (X) | Yes (X) | |||
| PATTY JO HERNDON | |||||||||
| VICE CHAIR | 1.00 | $0 | $0 | $0 | Yes (X) | Yes (X) | |||
| GARY BABCOCK | |||||||||
| TREASURER | 1.00 | $0 | $0 | $0 | Yes (X) | Yes (X) | |||
| KATHY L ZELENOCK | |||||||||
| SECRETARY | 1.00 | $0 | $0 | $0 | Yes (X) | ||||
| RASHID L BASHSHUR PH D | |||||||||
| IMMEDIATE PA | 1.00 | $0 | $0 | $0 | Yes (X) | 1.00 | Yes (X) | ||
| SHAHZAD MIAN MD | |||||||||
| MEDICAL DIRE | 1.00 | $0 | $0 | $0 | Yes (X) | ||||
| DANIELLE E D'ARCY | |||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | ||||
| ALAN DANINHIRSCH | |||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | ||||
| MAHMOUD N GHAZZI MD PHD | |||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | ||||
| JONATHAN LASS MD | |||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | ||||
| CAROLYN M WELSH | |||||||||
| DIRECTOR | 1.00 | $0 | $0 | $0 | Yes (X) | ||||
| CATHERINE MCCLORY | |||||||||
| DIR. COMPLIA | 50.00 | $127,223 | $0 | $29,505 | Yes (X) | ||||
| INDU VADAKKEPATTATH | |||||||||
| DATA SCI. & | 50.00 | $123,154 | $0 | $27,062 | Yes (X) | ||||
| ANDREA MEDRANO | |||||||||
| DIR. HUMAN R | 50.00 | $111,932 | $0 | $28,990 | Yes (X) | ||||
| KIMBERLY MCCULLOUGH | |||||||||
| DIR. MARKETI | 50.00 | $100,078 | $0 | $28,176 | Yes (X) | ||||
| ONKAR SAWANT | |||||||||
| DIR. RESEARC | 50.00 | $107,526 | $0 | $24,331 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,626,997 | TotalReportableCompFromOrgAmt |
| Total Other Compensation | $458,211 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 11 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
| Fundraising | $13,730 | FundraisingAmt |
| All Other Contributions | $658,640 | AllOtherContributionsAmt |
| Noncash Contributions | $198,142 | NoncashContributionsAmt |
| Total Contributions | $672,370 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| EYE TISSUE FEES | 621500 | $18,344,354 | $18,344,354 |
| INTERCOMPANY CHARGES | 621500 | $1,410,540 | $1,410,540 |
| OTHER REVENUE | 621500 | $94,848 | $94,848 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $19,849,742 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $142,247 | TotalRevenueColumnAmt |
| Exclusion | $142,247 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $4,491,516 | SecuritiesAmt |
| Other | $1,480,000 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $4,284,206 | SecuritiesAmt |
| Other | $1,375,895 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $207,310 | SecuritiesAmt |
| Other | $104,105 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $311,415 | TotalRevenueColumnAmt |
| Exclusion | $311,415 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $28,087 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $13,730 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $6,742 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $21,345 | TotalRevenueColumnAmt |
| Exclusion | $21,345 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $20,997,119 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $19,849,742 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $475,007 | ExclusionAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,043,967 | TotalAmt |
| Program Services | $235,668 | ProgramServicesAmt |
| Management And General | $662,774 | ManagementAndGeneralAmt |
| Fundraising | $145,525 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $333,264 | TotalAmt |
| Management And General | $333,264 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,285,145 | TotalAmt |
| Program Services | $5,260,442 | ProgramServicesAmt |
| Management And General | $1,739,015 | ManagementAndGeneralAmt |
| Fundraising | $285,688 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $434,861 | TotalAmt |
| Program Services | $316,878 | ProgramServicesAmt |
| Management And General | $102,075 | ManagementAndGeneralAmt |
| Fundraising | $15,908 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,172,447 | TotalAmt |
| Program Services | $889,417 | ProgramServicesAmt |
| Management And General | $255,190 | ManagementAndGeneralAmt |
| Fundraising | $27,840 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $649,032 | TotalAmt |
| Program Services | $423,584 | ProgramServicesAmt |
| Management And General | $195,431 | ManagementAndGeneralAmt |
| Fundraising | $30,017 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,024 | TotalAmt |
| Management And General | $9,024 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38,935 | TotalAmt |
| Management And General | $38,935 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $63,687 | TotalAmt |
| Management And General | $63,687 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $265,167 | TotalAmt |
| Program Services | $135,713 | ProgramServicesAmt |
| Management And General | $129,454 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $51,213 | TotalAmt |
| Program Services | $39,067 | ProgramServicesAmt |
| Management And General | $9,942 | ManagementAndGeneralAmt |
| Fundraising | $2,204 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,589,817 | TotalAmt |
| Program Services | $1,177,279 | ProgramServicesAmt |
| Management And General | $351,146 | ManagementAndGeneralAmt |
| Fundraising | $61,392 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $53,396 | TotalAmt |
| Program Services | $36,364 | ProgramServicesAmt |
| Management And General | $14,638 | ManagementAndGeneralAmt |
| Fundraising | $2,394 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $34,777 | TotalAmt |
| Program Services | $11,655 | ProgramServicesAmt |
| Management And General | $22,050 | ManagementAndGeneralAmt |
| Fundraising | $1,072 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $994 | TotalAmt |
| Management And General | $994 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $202,161 | TotalAmt |
| Program Services | $149,667 | ProgramServicesAmt |
| Management And General | $44,676 | ManagementAndGeneralAmt |
| Fundraising | $7,818 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $141,855 | TotalAmt |
| Program Services | $105,020 | ProgramServicesAmt |
| Management And General | $31,349 | ManagementAndGeneralAmt |
| Fundraising | $5,486 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| CLINICAL LAB & TECH EXP | $6,022,150 | $6,022,150 | ||
| MISCELLANEOUS | $287,417 | $6,122 | $281,193 | $102 |
| EQUIPEMENT RENTAL & MAINT | $220,491 | $163,237 | $48,727 | $8,527 |
| LICENSE AND REGISTRATIONS | $163,293 | $121,522 | $35,652 | $6,119 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $410,472 | TotalAmt |
| Program Services | $358,753 | ProgramServicesAmt |
| Management And General | $10,546 | ManagementAndGeneralAmt |
| Fundraising | $41,173 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,473,565 | TotalAmt |
| Program Services | $15,452,538 | ProgramServicesAmt |
| Management And General | $4,379,762 | ManagementAndGeneralAmt |
| Fundraising | $641,265 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,302,118 | BOYAmt |
| EOY | $4,492,241 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $146,130 | BOYAmt |
| EOY | $1,574,861 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,410 | BOYAmt |
| EOY | $20,000 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,570,865 | BOYAmt |
| EOY | $3,061,620 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $52,836 | BOYAmt |
| EOY | $84,373 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $16,321,009 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $8,730,140 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,536,161 | BOYAmt |
| EOY | $7,590,869 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,599,186 | BOYAmt |
| EOY | $7,895,493 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,719,649 | BOYAmt |
| EOY | $12,063,280 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $33,975,355 | BOYAmt |
| EOY | $36,782,737 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,925,490 | BOYAmt |
| EOY | $1,469,151 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $55,485 | BOYAmt |
| EOY | $34,333 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $349,000 | BOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $2,246,600 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,552,121 | BOYAmt |
| EOY | $18,700,616 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,882,096 | BOYAmt |
| EOY | $22,450,700 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,862,787 | BOYAmt |
| EOY | $14,153,738 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $230,472 | BOYAmt |
| EOY | $178,299 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,093,259 | BOYAmt |
| EOY | $14,332,037 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $33,975,355 | BOYAmt |
| EOY | $36,782,737 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $523,554 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $715,224 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org509a2 | Yes (X) | PubliclySupportedOrg509a2Ind |
Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $8,082 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $332,911 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $840,439 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,197,972 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $672,370 | CurrentTaxYearAmt |
| Total | $3,051,774 | TotalAmt |
Gross Receipts Admissions GrossReceiptsAdmissionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $17,098,627 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $10,344,492 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $21,135,494 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $21,313,494 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $19,849,742 | CurrentTaxYearAmt |
| Total | $89,741,849 | TotalAmt |
Total509 Total509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $17,106,709 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $10,677,403 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $21,975,933 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $22,511,466 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $20,522,112 | CurrentTaxYearAmt |
| Total | $92,793,623 | TotalAmt |
Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus2 Years | $25,000 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $25,000 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $28,750 | CurrentTaxYearAmt |
| Total | $78,750 | TotalAmt |
Substantial Contributors Amt SubstantialContributorsAmtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year | $8,766,065 | CurrentTaxYearAmt |
| Total | $8,766,065 | TotalAmt |
Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus2 Years | $25,000 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $25,000 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $8,794,815 | CurrentTaxYearAmt |
| Total | $8,844,815 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total509 | $83,948,808 | PublicSupportTotal509Amt |
Gross Investment Income509 GrossInvestmentIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $168,468 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $84,679 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $171,063 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $246,808 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $142,247 | CurrentTaxYearAmt |
| Total | $813,265 | TotalAmt |
Investment Income And UBTI InvestmentIncomeAndUBTIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $168,468 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $84,679 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $171,063 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $246,808 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $142,247 | CurrentTaxYearAmt |
| Total | $813,265 | TotalAmt |
Net Income From Other UBI NetIncomeFromOtherUBIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year | $20,345 | CurrentTaxYearAmt |
| Total | $20,345 | TotalAmt |
Other Income509 OtherIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $27,557 | CurrentTaxYearMinus4YearsAmt |
| Total | $27,557 | TotalAmt |
Total Support Calendar Year TotalSupportCalendarYearGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $17,302,734 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $10,762,082 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $22,146,996 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $22,758,274 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $20,684,704 | CurrentTaxYearAmt |
| Total | $93,654,790 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support CY509 | 0.89640 | PublicSupportCY509Pct |
| Public Support PY509 | 0.98260 | PublicSupportPY509Pct |
| Investment Income CY | 0.01000 | InvestmentIncomeCYPct |
| Investment Income PY | 0.01000 | InvestmentIncomePYPct |
| Thirty Thr Pct Suprt Tests CY509 | Yes (X) | ThirtyThrPctSuprtTestsCY509Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART III, LINE 12 | FormAndLineReferenceDesc |
| Explanation | MISCELLANEOUS 27,557 | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $179,087 | BeginningYearBalanceAmt |
| End Year Balance | $179,087 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $179,087 | BeginningYearBalanceAmt |
| End Year Balance | $179,087 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $179,087 | BeginningYearBalanceAmt |
| End Year Balance | $179,087 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $174,087 | BeginningYearBalanceAmt |
| Contributions | $5,000 | ContributionsAmt |
| End Year Balance | $179,087 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $174,087 | BeginningYearBalanceAmt |
| End Year Balance | $174,087 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.49000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.51000 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $7,364,420 | OtherCostOrOtherBasisAmt |
| Depreciation | $693,140 | DepreciationAmt |
| Book Value | $6,671,280 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $2,061,408 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,628,990 | DepreciationAmt |
| Book Value | $432,418 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $1,172,949 | OtherCostOrOtherBasisAmt |
| Depreciation | $845,614 | DepreciationAmt |
| Book Value | $327,335 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $5,722,232 | OtherCostOrOtherBasisAmt |
| Depreciation | $5,562,396 | DepreciationAmt |
| Book Value | $159,836 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $7,590,869 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (2 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| RECEIVABLE FROM RELATED ENTITY | $11,902,009 |
| DEPOSIT | $161,271 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $12,063,280 | TotalBookValueOtherAssetsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| PAYABLE TO RELATED ENTITY | $11,599,103 |
| CAPITAL LEASE | $7,101,513 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $18,700,616 | TotalLiabilityAmt |
| Total Rev Etc Audited Fincl Stmt | $21,655,398 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $715,224 | NetUnrealizedGainsInvstAmt |
| Other Revenue | $6,742 | OtherRevenueAmt |
| Revenue Not Reported | $721,966 | RevenueNotReportedAmt |
| Revenue Subtotal | $20,933,432 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $63,687 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $63,687 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $20,997,119 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $20,416,620 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $6,742 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $6,742 | ExpensesNotReportedAmt |
| Expenses Subtotal | $20,409,878 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $63,687 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $63,687 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $20,473,565 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PAGE 2, PART V, LINE 4 | THE PURPOSE OF THE GIFT OF HOPE EYE AND VISION RESEARCH ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S GIFT OF HOPE EYE AND VISIONS RESEARCH PROGRAM. THE PURPOSE OF THE GIFT OF SIGHT CHARITABLE ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S PROGRAM WHICH WAIVES TISSUE PROCESSING FEES, OR REDUCES THE FEE FOR PATIENTS WHO ARE UNABLE TO PAY THE FULL AMOUNT. THE PURPOSE OF THE COMMUNITY EDUCATION ENDOWMENT FUND IS TO PROVIDE FOR ANNUAL DISTRIBUTIONS TO SUPPORT EVERSIGHT'S COMMUNITY EDUCATION PROGRAM. |
| SCHEDULE D, PAGE 4, PART XI, LINE 2D | SPECIAL EVENTS EXPENSES 6,742 |
| SCHEDULE D, PAGE 4, PART XII, LINE 2D | SPECIAL EVENTS EXPENSES 6,742 |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | GOLF OUTING | Event1Nm |
| Gross Receipts Event1 | $31,887 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $9,154 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $22,733 | GrossRevenueEvent1Amt |
| Non Cash Prizes Event1 | $233 | NonCashPrizesEvent1Amt |
| Other Direct Expenses Event1 | $2,042 | OtherDirectExpensesEvent1Amt |
| Event2 | SIP & SUPPORT | Event2Nm |
| Gross Receipts Event2 | $9,930 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $4,576 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $5,354 | GrossRevenueEvent2Amt |
| Food And Beverage Event2 | $4,467 | FoodAndBeverageEvent2Amt |
| Gross Receipts Total | $41,817 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $13,730 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $28,087 | GrossRevenueTotalEventsAmt |
| Non Cash Prizes Total Events | $233 | NonCashPrizesTotalEventsAmt |
| Food And Beverage Total Events | $4,467 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $2,042 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $6,742 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | $21,345 | NetIncomeSummaryAmt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt |
|---|---|---|---|---|
| DAVID BOSCH | ||||
| PRESIDENT & CEO | $261,757 | $15,277 | $56,230 | $333,264 |
| MICHAEL O'KEEFE | ||||
| COO | $184,030 | $11,294 | $40,344 | $235,668 |
| JULIE COLLINS | ||||
| CFO | $187,675 | $12,220 | $40,344 | $240,239 |
| MICHAEL TITUS | ||||
| VP CLINICAL SERVICES | $150,924 | $11,199 | $42,377 | $204,500 |
| DIANE HOLLINGSWORTH | ||||
| PRESIDENT & CEO | $172,568 | $10,640 | $34,827 | $218,035 |
| CATHERINE MCCLORY | ||||
| DIR. COMPLIANCE & QC | $127,223 | $8,497 | $21,008 | $156,728 |
| INDU VADAKKEPATTATH | ||||
| DATA SCI. & APP MGR. | $123,154 | $8,380 | $18,682 | $150,216 |
Schedule M IRS990ScheduleM
Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)
| Non Cash CheckboxNonCashCheckboxInd | DescDesc | ContributionContributionCnt | Noncash Contributions Rpt F990NoncashContributionsRptF990Amt | Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt |
|---|---|---|---|---|
| Yes (X) | VARIOUS | 47 | $97,502 | FMV |
| Yes (X) | SOFTWARE | 1 | $100,000 | FMV |
| Yes (X) | GIFT CARDS | 6 | $640 | FMV |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | false | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (11 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990 - ORGANIZATION'S MISSION | EVERSIGHT'S MISSION IS TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH THE HEALING POWER OF DONATION, TRANSPLANTATION AND RESEARCH. BLINDING EYE DISEASES AFFECT 80 MILLION AMERICANS. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, DRIVE TO WORK OR READ THE NEWSPAPER ON A SUNDAY MORNING. THEIR VISION LOSS RESULTS IN AN ECONOMIC IMPACT OF 51.4 BILLION EVERY YEAR IN THE UNITED STATES ALONE. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL MOTHERS CAN SEE THEIR CHILDREN AND ALL CHILDREN CAN GROW UP TO LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. TO MAKE VISION A REALITY FOR ALL, EVERSIGHT CONTINUOUSLY WORKS TO EXPAND ITS REACH, CONNECT MORE EFFECTIVELY WITH COMMUNITIES IN NEED AND PROVIDE THE GIFT OF SIGHT TO EVERYONE. |
| FORM 990, PAGE 1, PART I, LINE 6 | VOLUNTEERS PROVIDE VARIOUS TYPES OF SERVICES, INCLUDING LEADERSHIP, THROUGH OUR BOARD OF DIRECTORS (NATIONAL), AND OUR SERVICE AREA ADVISORY BOARDS. WE ALSO WORK WITH MEMBERS OF THE LIONS CLUB IN MICHIGAN AND THROUGHOUT OUR SERVICE AREAS TO SHARE INFORMATION ABOUT EVERSIGHT AND EYE DONATION, AND TO GATHER INTEL AND FACILITATE MEANINGFUL CONNECTIONS IN THE LOCAL COMMUNITIES WE SERVE. VOLUNTEERS HELP PLAN EVENTS SUCH AS OUR ILLINOIS GIFT OF SIGHT CHARITY EVENT, AND OUR MICHIGAN-BASED GIFT OF SIGHT GOLF CLASSIC, AND SERVE AS REPRESENTATIVES AT DONOR FAMILY GATHERINGS AND OTHER EVENTS. |
| FORM 990, PAGE 2, PART III, LINE 4A | RESORING SIGHT IN 2020, EVERSIGHT PROVIDED THE GIFT OF SIGHT TO MORE THAN 6,500 PEOPLE ACROSS THE UNITED STATES AND AROUND THE WORLD. EVERSIGHT'S WORK BEGAN IN 1947 WITH THE ESTABLISHMENT OF THE FOURTH EYE BANK IN THE UNITED STATES, THEN KNOWN AS THE ILLINOIS EYE-BANK. OVER TIME, NONPROFIT EYE BANKS WERE ESTABLISHED IN EVERY STATE TO MEET THE CRITICAL DEMAND FOR CORNEAL TISSUE TO TREAT PREVENTABLE BLINDNESS. IN 1985, THE ILLINOIS EYE-BANK AND MICHIGAN EYE-BANK FORMED A PARTNERSHIP- ONE THAT WOULD EARN A REPUTATION FOR CLINICAL EXCELLENCE MADE POSSIBLE BY SOME OF THE FINEST MEDICAL DIRECTORS, STAFF AND BOARD MEMBERS IN THE EYE BANKING FIELD. THE SUCCESS OF THE ORGANIZATION ATTRACTED AFFILIATIONS WITH OTHER REGIONAL EYE BANKS FORMING ONE OF THE LARGEST NETWORKS OF EYE BANKS IN THE U.S. IN 2015, THE NETWORK BECAME KNOWN AS EVERSIGHT, ALL WORKING TOGETHER AS A UNIFIED OPERATION TO DELIVER THE HIGHEST QUALITY SERVICES TO SURGEONS AND THEIR PATIENTS AND TO CONTINUE TO GROW OUR IMPACT AROUND THE WORLD. EVERSIGHT FACED CHALLENGES IN 2020 AND SAW THEM THROUGH TO SERVE OUR SURGEONS, THEIR PATIENTS AND DONOR FAMILIES. ON MARCH 18, 2020, U.S. CORNEA TRANSPLANTS WERE IMMEDIATELY HALTED DUE TO THE PANDEMIC. NO ONE KNEW HOW LONG IT WOULD LAST, BUT WITH SACRIFICE, INNOVATION AND STEADFAST DETERMINATION, WE KEPT HOPE IN SIGHT. AS THE VIRUS RAPIDLY SPREAD, NO ONE KNEW WHEN TRANSPLANTS MIGHT RESUME AND THE FINANCIAL IMPACT WAS IMMEDIATE. PROVIDING FOR CORNEA TRANSPLANTATION ACCOUNTS FOR 94 PERCENT OF EVERSIGHT'S OPERATING REVENUE, AND LIKE MANY NONPROFITS, WE CANCELED FUNDRAISERS WE COUNT ON TO SUPPORT OUR WORK. THAT INCLUDED OUR ANNUAL GALA, OUR LARGEST ANNUAL FUNDRAISER TO HELP LOW-INCOME PATIENTS. MEANWHILE, THE PANDEMIC WAS ELIMINATING JOBS AND HEALTH INSURANCE COVERAGE AT HISTORIC RATES ACROSS THE COUNTRY. EVEN WITH NO REVENUE COMING IN, WE DEVELOPED NEW PROTOCOLS, TESTING, TRAINING AND READINESS TO MEET THE DEMAND ONCE TRANSPLANTS COULD RESUME. IN JUNE 2020, WE WENT ABOVE AND BEYOND REGULATORY GUIDANCE AND BEGAN TESTING POTENTIAL SURGICAL TISSUE DONORS FOR SARS-COV-2. THE TEAM'S EXPERTISE AND OUR RIGOROUS STANDARDS HELPED ENSURE PATIENT SAFETY AND THE SAFETY OF DONORS' GIFTS OF TISSUE FOR TRANSPLANTATION, ONCE TRANSPLANTS COULD RESUME. IN THIS NEW PHYSICALLY DISTANCED WORLD, WE QUICKLY DEVELOPED AND BEGAN OFFERING VIRTUAL WEBINARS TO HELP SURGEONS STAY ON TOP OF EVOLVING TECHNOLOGY AND COVID-19 SCIENCE AND SAFETY. EVERSIGHT BECAME THE FIRST EYE BANK TO DEVELOP VIRTUAL WET LAB TRAINING FOR SURGEONS TO PRACTICE THEIR SURGICAL TECHNIQUES. WE PROVIDED THE TECHNOLOGY FOR SURGEONS-WHEREVER THEY ARE IN THE WORLD-TO COME TOGETHER ONLINE AND PRACTICE WITH INDIVIDUALIZED REAL-TIME GUIDANCE FROM LEADING SURGEON INSTRUCTORS. MORE THAN 640 SURGEONS AND OTHER CLINICIANS RECEIVED TRAINING THROUGH EVERSIGHT IN 2020, MORE THAN DOUBLING OUR IMPACT OVER ANY PRIOR YEAR. |
| FORM 990, PAGE 2, PART III, LINE 4B | FINDING A CURE IN THE PURSUIT TO ELIMINATE BLINDING EYE DISEASES, EVERSIGHT ESTABLISHED THE EVERSIGHT CENTER FOR VISION AND EYE BANKING RESEARCH IN CLEVELAND, OHIO, TO PROVIDE LEADING OPHTHALMOLOGY RESEARCHERS WITH THE RESOURCES THEY NEED TO FIND CURES AND TREATMENTS FOR EYE DISEASES SUCH AS AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY AND GLAUCOMA. EVERSIGHT PROVIDED MORE THAN 2,600 TISSUES FOR RESEARCH AND EDUCATION PURPOSES IN 2020. OUR IN-HOUSE RESEARCH TEAM ALSO PROVIDED EVERSIGHT PARTNERS WITH VALUABLE RESEARCH AND DEVELOPMENT SERVICES, AND PIONEERED NEW EYE BANKING PRACTICES, INCLUDING CRITICAL CLINICAL ADAPTATIONS FOR TISSUE SAFETY DURING THE PANDEMIC. OUR RESEARCH AND CLINICAL LEADERSHIP AND STAFF ARE HIGHLY INVOLVED PRIMARY AND CO-INVESTIGATORS, PERFORMING RESEARCH AND AUTHORING PUBLICATIONS THAT EXPAND THE BOUNDARIES OF VISION SCIENCE, KNOWLEDGE AND POSSIBILITY. EVERSIGHT PRODUCED THE RESEARCH THE WORLD NEEDED IN 2020, INVESTIGATING IF SARS-COV-2 IS PRESENT IN EYE TISSUE. OUR WORK TOOK PLACE IN CLEVELAND, CHICAGO, ANN ARBOR AND IN NEW JERSEY-ALL HEAVILY IMPACTED BY COVID-19-WITH RESEARCH PARTNERS AT CHICAGO CORNEA CONSULTANTS AND RUSH UNIVERSITY, KELLOGG EYE CENTER AND THE UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, AND WAYNE STATE UNIVERSITY. BY OCTOBER 2020, OUR FINDINGS SHOWED A SMALL BUT NOTEWORTHY PREVALENCE OF SARS-COV-2 IN OCULAR TISSUES FROM INDIVIDUALS WHO DIED FROM COVID-19. OUR RESEARCH CONTINUES FOR ALL THOSE IN NEED OF SAFE SIGHT-RESTORING TRANSPLANTS AND FOR ALL THOSE AWAITING A CURE FOR NON- CORNEAL BLINDNESS. EVERSIGHT HAS A LONGSTANDING TRACK RECORD OF RESEARCH AND DEVELOPMENT, TO DATE AWARDING MORE THAN 4 MILLION IN GRANTS THAT STIMULATE PIONEERING CLINICAL AND BASIC SCIENCE RESEARCH AIMING TO DEVELOP NEW WAYS TO RESTORE SIGHT, PREVENT BLINDNESS AND ULTIMATELY HELP PATIENTS LIVE LIFE TO THE FULLEST. SINCE 1980, OUR EYE & VISION RESEARCH GRANT PROGRAM HAS SUPPORTED RESEARCHERS AT LEADING ACADEMIC MEDICAL INSTITUTIONS INCLUDING HARVARD, TUFTS, CLEVELAND CLINIC, CASE WESTERN RESERVE, UNIVERSITY OF MICHIGAN, NORTHWESTERN AND MORE. BY DESIGN, EVERSIGHT'S GRANT PROGRAM PROVIDES CRITICAL, EARLY-STAGE FUNDING THAT IS INTENDED TO DRIVE FOUNDATIONAL RESEARCH AND DISCOVERY. MANY OF THESE PROJECTS HAVE STIMULATED LARGER-SCALE STUDIES AND WON FURTHER FINANCIAL SUPPORT FROM THE NATIONAL INSTITUTES OF HEALTH. IN THE 2020-2021 FUNDING CYCLE, EVERSIGHT AWARDED GRANTS TO ADVANCE STUDIES ON TRANSPLANT GRAFT REJECTION, SARS-COV-2 AND THE EYE, FUCHS DYSTROPHY, DRY EYE AND NOVEL CORNEA THERAPIES, LED BY RESEARCHERS AT HARVARD MEDICAL SCHOOL, UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE AND WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE. EACH YEAR, RECIPIENTS ARE SELECTED BY AN INDEPENDENT REVIEW PANEL OF ACADEMIC RESEARCHERS AND OPHTHALMOLOGISTS. THIS DISTINGUISHED PANEL AWARDS PROPOSALS THAT ALIGN WITH EVERSIGHT'S MISSION TO RESTORE SIGHT AND PREVENT BLINDNESS THROUGH MEANINGFUL SCIENTIFIC INQUISITION. |
| FORM 990, PAGE 2, PART III, LINE 4C | SUSTAINABLE INTERNATIONAL IMPACT EVERSIGHT WORKED WITH SURGEONS IN 27 COUNTRIES IN 2020 TO PROVIDE THE GIFT OF SIGHT THROUGH SURGICAL TISSUE PROVISION. EVERSIGHT IS FOCUSED ON MEETING THE HUMANITARIAN NEED FOR CORNEA TISSUES IN COUNTRIES WHERE SIGHT-RESTORING CORNEAL TRANSPLANT PROCEDURES WOULD OTHERWISE BE COMPLETELY UNAVAILABLE. THE BENEFICIARIES OF OUR SURGICAL TISSUE PROVISION AND COMMUNITY EYE BANK DEVELOPMENT INITIATIVES INCLUDE THE HUNDREDS OF THOUSANDS OF PEOPLE WHO SUFFER FROM EYE INJURIES AND BLINDING EYE DISEASES THAT CAN BE TREATED THROUGH CORNEAL TRANSPLANTATION. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. TO ADDRESS SYSTEMIC UNMET NEED, EVERSIGHT ACTIVELY WORKS WITH MEDICAL PROFESSIONALS, GOVERNMENTS, VISION HEALTH ORGANIZATIONS AND OTHER NGOS IN REGIONS LACKING EYE BANKS AND INFRASTRUCTURE, INCLUDING THE MIDDLE EAST, PAKISTAN AND SOUTH KOREA. WITH PROVEN EYE BANKING AND TECHNICAL TRAINING PRACTICES-AND HAVING PLAYED A PART IN THE ELIMINATION OF THE U.S. CORNEA TRANSPLANT WAITING LIST-EVERSIGHT UNIQUELY QUALIFIED TO WORK WITH COUNTRIES LACKING TRANSPLANT PROGRAMS TO HELP THEM ESTABLISH A NATIONAL NETWORK FOR EYE BANKING AND CORNEA DONATION WITH CULTURALLY APPROPRIATE DONATION MODELS AND STATE-OF-THE-ART CLINICAL CAPABILITIES. EIGHTY-NINE PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. IN 2019, EVERSIGHT WORKED WITH PAKISTAN TO OPEN ITS FIRST STATE-OF-THE-ART EYE BANKS AS PART OF A NEW NATIONAL EYE BANKING NETWORK. THE PANDEMIC SUSPENDED MOST OF OUR PLANNED WORK FOR 2020 TO HELP PAKISTAN DEVELOP ITS EYE BANKING AND COMMUNITY DONATION PROGRAM. DESPITE THE CHALLENGES OF THE PANDEMIC, THE NEW AL SHIFA EYE BANK IN RAWALPINDI WORKED WITH ITS FIRST EVER LOCAL EYE TISSUE DONOR IN JULY 2020. WE COLLABORATED WITH AL SHIFA STAFF ON OPTIMIZING DONOR FAMILY AND RECIPIENT COMMUNICATIONS, AND SUPPORTED THEIR FIRST-EVER PUBLIC OUTREACH CAMPAIGN. THE WORK CONTINUES-AND IT HAS GENERATED A NATIONAL MOVEMENT FOR ORGAN, TISSUE AND EYE DONOR REGISTRATION LED BY LOCAL PROFESSIONALS WHO TIRELESSLY EDUCATE AND ADVOCATE FOR THE GIFT OF SIGHT. BLINDING EYE DISEASES AFFECT HUNDREDS OF MILLIONS WORLDWIDE. GLOBALLY, AN ESTIMATED 285 MILLION PEOPLE ARE VISUALLY IMPAIRED-MANY WITH TREATABLE CONDITIONS, BUT WITHOUT ACCESS TO CARE. THAT MEANS MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, LET ALONE WORK TO PROVIDE FOR THEIR FAMILIES. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE IN THEIR COMMUNITIES. EVERSIGHT ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. WHILE PROVIDING FOR IMMEDIATE GLOBAL CORNEA TRANSPLANT NEEDS WITH U.S. DONOR TISSUE, EVERSIGHT CONTINUES TO EMPOWER INTERNATIONAL COMMUNITIES TO TAKE MEANINGFUL, SUSTAINABLE STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL. |
| FORM 990, PAGE 6, PART VI, LINE 11B | THE 990 IS REVIEWED BY THE CEO AND CFO PRIOR TO FILING. COMPLETED 990 IS PROVIDED VIA E-MAIL TO ALL BOARD MEMBERS FOR COMMENTS AND QUESTIONS PRIOR TO FILING. |
| FORM 990, PAGE 6, PART VI, LINE 12C | THE POLICY IS REVIEWED DURING NEW EMPLOYEE ORIENTATION AND ANNUALLY WITH THE ENTIRE STAFF AND BOARD OF DIRECTORS. ANY POTENTIAL CONFLICTS OF INTEREST ARE REVIEWED BY SENIOR STAFF UPON DISCOVERY. |
| FORM 990, PAGE 6, PART VI, LINE 15A | A PERFORMANCE REVIEW IS CONDUCTED BY THE BOARD HR COMMITTEE WITH CEO; MERIT INCREASE IS RECOMMENDED BY THE HR COMMITTEE AND APPROVED BY THE BOARD. THE CEO IS NOT PART OF COMPENSATION DISCUSSION AND CEO DOES NOT PARTICIPATE IN THE SELECTION OF BOARD MEMBERS. THE CEO SALARY IS COMPARED TO SALARIES OF OTHER CEO'S AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. IN 2016 THE ORGANIZATION ENGAGED THE SERVICES OF AN INDEPENDENT CONSULTANT TO CONDUCT A LEADERSHIP COMPENSATION ANALYSIS. THEIR SOURCE OF SALARY INFORMATION IS THE 990'S ISSUED BY PEER ORGANIZATIONS, MICHIGAN NONPROFIT ASSOCIATION SALARY SURVEY, PUBLISHED BUDGETS, WEB-BASED RESEARCH THROUGH FOIA SOURCES AND INDEPENDENT SALARY SURVEY DATA. |
| FORM 990, PAGE 6, PART VI, LINE 15B | PERFORMANCE REVIEW FOR OFFICERS AND KEY EMPLOYEES IS CONDUCTED BY THE EMPLOYEES' IMMEDIATE MANAGER; MERIT INCREASES ARE RECOMMENDED BY THE MANAGER AND APPROVED BY THE CEO. SALARIES OF OFFICERS AND KEY EMPLOYEES ARE COMPARED TO SALARIES OF OTHER SIMILAR POSITIONS AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE. A REPORT IS PROVIDED TO THE HR COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. IN 2016 THE ORGANIZATION ENGAGED THE SERVICES OF AN INDEPENDENT CONSULTANT TO CONDUCT A LEADERSHIP COMPENSATION ANALYSIS. THEIR SOURCE OF SALARY INFORMATION IS THE 990'S ISSUED BY PEER ORGANIZATIONS, MICHIGAN NONPROFIT ASSOCIATION SALARY SURVEY, PUBLISHED BUDGETS, WEB-BASED RESEARCH THROUGH FOIA SOURCES AND INDEPENDENT SALARY SURVEY DATA. |
| FORM 990, PAGE 6, PART VI, LINE 19 | GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. |
| FORM 990, PART XI, LINE 9 | SPECIAL EVENTS EXPENSES 6,742 SPECIAL EVENTS EXPENSES -6,742 |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (7 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Business Name Line2DirectControllingEntityName/BusinessNameLine2Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVERSIGHT INTERNATIONAL | |||||||||||
| 3985 RESEARCH PARK DRIVE | ANN ARBOR | MI | 48108 | 471671769 | EYE BANK | MI | 3 | 10 | EVERSIGHT | EVERSIGHT | Yes (true) |
| EVERSIGHT NEW JERSEY | |||||||||||
| 77 BRANT AVE SUITE 100 | CLARK | NJ | 07066 | 203345087 | EYE BANK | NJ | 3 | 7 | EVERSIGHT | EVERSIGHT | Yes (true) |
| EVERSIGHT MICHIGAN | |||||||||||
| 3985 RESEARCH PARK DRIVE | ANN ARBOR | MI | 48108 | 273107692 | EYE BANK | MI | 3 | 7 | EVERSIGHT | EVERSIGHT | Yes (true) |
| EVERSIGHT ILLINOIS | |||||||||||
| 547 WEST JACKSON BLVD SUITE 600 | CHICAGO | IL | 60661 | 273107617 | EYE BANK | IL | 3 | 7 | EVERSIGHT | EVERSIGHT | Yes (true) |
| MIDWIRE SYSTEMS | |||||||||||
| 3985 RESEARCH PARK DRIVE | ANN ARBOR | MI | 48108 | 383557111 | SOFTWARE | MI | 3 | 10 | EVERSIGHT | EVERSIGHT | Yes (true) |
| EVERSIGHT OHIO | |||||||||||
| 6700 EUCLID AVE SUITE 101 | CLEVELAND | OH | 44103 | 455111431 | EYE BANK | OH | 3 | 7 | EVERSIGHT | EVERSIGHT | Yes (true) |
| EVERSIGHT CONNECTICUT | |||||||||||
| 3985 RESEARCH PARK DRIVE | ANN ARBOR | MI | 48108 | 475113503 | EYE BANK | CT | 3 | 7 | EVERSIGHT | EVERSIGHT | Yes (true) |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EVERSIGHT KOREA LLC | BusinessNameLine1Txt |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 145 A 1638 TEHRAN-RO | AddressLine1Txt |
| City | GUMCHEONGU SEOUL | CityNm |
| Province Or State | GUMCHEON-GU SEOUL | ProvinceOrStateNm |
| Country | KS | CountryCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | EYE BANK | PrimaryActivitiesTxt |
| Legal Domicile Foreign Country | KS | LegalDomicileForeignCountryCd |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | EVER INT | BusinessNameLine1Txt |
| Business Name Line2 | EVERSIGHT INTERNATIONAL | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Entity Type | C CORP | EntityTypeTxt |
| Controlled Organization | false | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (true) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (2 entries)
| Business Name Line2OtherOrganizationName/BusinessNameLine2Txt | Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|---|
| EVERSIGHT INTERNATIONAL | |||
| 274622 | O | $324,440 | COST |
| EVERSIGHT INTERNATIONAL | |||
| 231250 | L | $1,086,100 | COST |
Comments